Koch Marcus, Mostert Jop, Heersema Dorothea, De Keyser Jacques
Department of Neurology, University Medical Centre Groningen, University of Groningen, Hanzeplein 1, 9713 GZ Groningen, The Netherlands.
J Neurol Sci. 2007 Apr 15;255(1-2):35-41. doi: 10.1016/j.jns.2007.01.067. Epub 2007 Feb 27.
The relapsing-remitting phase and the progressive phase of multiple sclerosis (MS) seem to be the result of distinct pathophysiological processes. Previous research on the natural history of MS was largely focussed on relapses and disability scores. In this study we evaluated 438 patients with secondary or primary progressive MS. The influence of gender, initial disease course, onset manifestation and age at disease onset on age at progression and time to progression were evaluated with Kaplan-Meier survival analysis and Cox multivariate regression models. The analysis of these data showed that the initial disease course (SPMS or PPMS) had no influence on the age at progression. Gender had no influence on age at progression in PPMS and SPMS patients nor on time to progression in SPMS patients. PPMS patients with visual or brainstem/cerebellar onset had a significantly younger age at progression. SPMS patients with motor onset had a significantly higher age at progression and longer time to progression. Time to progression was significantly shorter in SPMS patients with higher age at disease onset. Our data give further support to the notion that progression in MS is an age dependent process independent of relapses.
复发缓解型和继发进展型多发性硬化(MS)似乎是不同病理生理过程的结果。先前关于MS自然史的研究主要集中在复发和残疾评分上。在本研究中,我们评估了438例继发或原发进展型MS患者。采用Kaplan-Meier生存分析和Cox多因素回归模型评估性别、初始病程、起病表现和起病年龄对进展年龄和进展时间的影响。对这些数据的分析表明,初始病程(继发进展型MS或原发进展型MS)对进展年龄没有影响。性别对原发进展型MS和继发进展型MS患者的进展年龄均无影响,对继发进展型MS患者的进展时间也无影响。以视觉或脑干/小脑起病的原发进展型MS患者进展年龄显著更小。以运动起病的继发进展型MS患者进展年龄显著更高,进展时间更长。起病年龄较大的继发进展型MS患者进展时间显著更短。我们的数据进一步支持了MS进展是一个与复发无关的年龄依赖性过程这一观点。